quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:18:10·44d
SECFiling
Lantheus Holdings Inc. logo

SEC Form PRE 14A filed by Lantheus Holdings Inc.

LNTH· Lantheus Holdings Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • LNTH
    Lantheus Holdings Inc.
    Health Care

Recent analyst ratings

  • Feb 26UpdateWilliam Blair-
  • Dec 12UpdateTruist$80.00
  • Oct 8UpdateGoldman$77.00
  • Aug 12UpdateTruist$63.00
  • Dec 18UpdateGoldman$143.00
  • Sep 3UpdateRedburn Atlantic$175.00

Related

  • PR23h
    Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
  • INSIDER2d
    SEC Form 4 filed by Niedzwiecki Daniel
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Lantheus Holdings Inc.
  • SEC34d
    SEC Form DEFA14A filed by Lantheus Holdings Inc.
  • SEC34d
    SEC Form DEF 14A filed by Lantheus Holdings Inc.
  • PR37d
    Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
  • INSIDER45d
    Officer Niedzwiecki Daniel was granted 36,692 shares and covered exercise/tax liability with 1,283 shares, increasing direct ownership by 42% to 119,376 units (SEC Form 4)
  • INSIDER45d
    Officer Dinkelborg Ludger was granted 20,966 shares, increasing direct ownership by 142% to 35,731 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022